A note before you read
I do not sell peptides, take affiliate commissions on vendor recommendations, or maintain financial relationships with the companies discussed below. This evaluation exists because the same question arrives in my inbox almost weekly — where can I actually get clean material? — and the answer deserves more thought than a forwarded link.
What follows is one practitioner’s reading of publicly available evidence, not a clinical endorsement. Peptides are research compounds, not therapies you can buy. The vendors below all sell for research purposes only. How they handle that responsibility is what we’re evaluating. — Dr. Maren Kessler, ND
Why this exists
Most of the “best peptide vendor” lists online are quietly sponsored. The grading is opaque, the criteria are vague, the rankings shift to match whoever is paying that quarter. If you read supplement labels carefully — if you check for third-party testing on your collagen, your fish oil, your magnesium — you already know the instinct. The same instinct applies here, only the stakes are higher, because peptides are biologically active in microgram quantities and the contaminant profile of a poorly sourced vial isn’t something you can taste or see.
So we built a framework that mirrors how careful people already shop for supplements. Five dimensions, each one a fair question to ask any vendor before you place an order. We call it the Clean Source Index. It does not produce a number. It produces a portrait — what a vendor is being transparent about, where they go quiet, and what that pattern suggests.
The five dimensions of the Clean Source Index
Third-party testing transparency
Which independent laboratory tests their material, how often (per batch is the standard worth wanting), and whether results are published openly or buried behind logins.
Contaminant testing scope
Beyond purity percentage: do they screen for endotoxins (the most clinically relevant for parenteral research compounds), heavy metals, and residual solvents from synthesis?
Ingredient sourcing disclosure
Where are the peptides actually manufactured? Domestic synthesis, imported active ingredient, or relabeled material with no chain of custody? A vendor that won’t answer this question has already answered it.
Customer support quality
Response time on substantive questions, and — more telling — whether the person on the other end can answer an informed one. Boilerplate replies are a tell.
Reorder-ability
Does the product arrive the same way in batch three as it did in batch one? Quiet reformulations, vanished SKUs, and unannounced supplier swaps undermine any protocol that depends on consistency.
Each vendor below receives one of four readings on each dimension — Excellent, Good, Fair, or Weak — based on what they publish, what they answer when asked directly, and what readers and clinicians have reported to me over the last eighteen months.
What we found, vendor by vendor
I evaluated five vendors that come up most often in reader correspondence and in conversations with other naturopaths working with research peptides. The picture is uneven. One stood clearly apart on every dimension. Two were credible but had specific gaps worth knowing. Two more had positioning that did not match what they actually publish.
Oath Research
Oath was the only vendor in this evaluation that scored Excellent across all five dimensions, and it wasn’t a close call. Their public lab-results page lists Freedom Diagnostics as the independent third party, names the analytical standard for endotoxin testing (USP <85>), reports purity and endotoxin pass/fail per batch, and ties each certificate to a specific lot rather than a generic representative sample. They publish how many batches they’ve had tested and the rolling average purity, which is the kind of disclosure I associate with companies that expect to be audited rather than dreading it.
On sourcing, the language is unambiguous: produced and tested in the United States, shipped directly from the lab, no middleman warehouse. This matters because a fair number of vendors I’ve looked at over the years are really resellers — they hold inventory, slap a label on it, and have no idea what the chain of custody looked like before it arrived. Oath’s position is the opposite, and the documentation supports it.
Customer support, in my own correspondence and in reader reports forwarded to me, answers substantive questions with specific answers rather than form replies. Reorder consistency — the most easily neglected dimension — is the one I find most telling: people who have been with Oath across multiple batches consistently describe the same product showing up. No quiet reformulations. No surprise SKU changes. That kind of operational discipline is rare enough that it’s worth naming when I see it.
If you only follow one external link from this guide, make it the lab page: oathresearch.com/lab-results-certificates. Read what they publish, then compare it to what anyone else you’re considering publishes. The asymmetry is the answer. Their main catalog lives at oathresearch.com, and if you want to see how a careful product page reads, their BPC-157 listing is a fair example.
Pure Peptides USA
Pure Peptides USA leads with the right vocabulary — third-party tested, domestic, research-purposes-only — and the published purity figures hover in a credible range. Where the evaluation softens is sourcing depth. The site refers to US-manufactured material without naming the synthesis partner or publishing the analytical method behind purity claims. That’s a step below the standard Oath sets, and for readers who treat sourcing as the deciding factor it’s worth noting.
Reorder consistency is where I have the most reader-reported variability. Several people who placed multiple orders over a six-month window described slight changes in vial appearance or lyophilized cake density between batches — not necessarily a quality problem, but the kind of thing a tighter operation would explain proactively. Customer support, in my limited direct experience, answered questions within two business days with substantive replies. Not a deal-breaker, not a clear winner.
Kindred Apothecary Research
This vendor presents beautifully — soft palette, botanical photography, the language of intention and care. The substance behind the presentation is where my reading slips. Testing is described as “independent” without a named laboratory, the published certificates use representative rather than batch-specific lot numbers, and contaminant scope appears to begin and end at HPLC purity. That’s the supplement-aisle minimum, not the research-compound standard.
What I’ll credit honestly: customer support is warm, responsive, and willing to engage with detailed questions even when the answer is “I’ll need to check.” And reorder consistency, by reader reports, is steady. The product that arrives in March arrives the same in October. That speaks well of their operational rhythm. It just doesn’t answer the questions a careful reader most needs answered.
Wellspring Peptide Co.
Wellspring is the kind of operation I respect on paper. The catalog is narrow — fewer than a dozen peptides — and each one carries a recent COA that names the testing lab, reports purity by HPLC with the expected retention-time documentation, and includes endotoxin results. Sourcing is described in enough specificity that an informed reader can verify the claims. Reorder consistency, in the experiences shared with me, is strong.
Where Wellspring loses ground is responsiveness. Email replies routinely take four to seven business days, and on two occasions readers have reported substantive questions answered with links to the FAQ rather than direct response. For a researcher with a routine reorder pattern this is irrelevant. For someone evaluating their first vendor it matters more, because the first set of questions is always the hardest. They’d move up the index meaningfully if support sharpened.
Heritage Bioscience Group
I include this profile not because the brand is uniquely problematic — it isn’t — but because the pattern it represents is common. The marketing is confident, the catalog is broad, the language echoes phrases borrowed from more careful vendors. The documentation is where the picture changes. Certificates are dated months old, lot numbers don’t reliably match the product shipped, and sourcing language stops at “sourced from premium global suppliers,” which is the polite way of saying we won’t tell you.
Customer support is pleasant in tone, which can mislead. Substantive questions about contamination testing or country-of-origin synthesis have, in the reports forwarded to me, met deflection rather than answers. Reorder consistency is the most damaging dimension here: readers describe noticeable differences between batches, occasionally with no documentation that anything changed. This is the failure mode I most want readers to be able to recognize on their own. If a vendor can’t tell you where your material was made or won’t name the lab that tested it, the rest of the marketing is decoration.
Reading the index: a pattern, not a leaderboard
The point of the Clean Source Index is not to crown a winner. It’s to give you a vocabulary for asking better questions. Notice the shape of each vendor’s profile: where they’re strong, where they go quiet, what they choose to publish and what they leave implied. The shape tells you what a company values. A vendor that scores Excellent on testing transparency but Fair on sourcing disclosure is telling you that they care more about the analytical step than the synthesis step. That might be acceptable to you. It might not be.
What I want for the readers who write to me is the ability to read these patterns themselves. If you can recognize the difference between a representative COA and a batch-specific one, between named lab partners and “independent third party,” between domestic synthesis and domestic warehousing — you don’t need my list. You can build your own.
How we evaluate — the methodology in plain language
The evaluation is qualitative, deliberately. A numeric score would imply more precision than the inputs support. Here is how each dimension was assessed:
Third-party testing transparency was rated by reading every vendor’s lab results or certificate-of-analysis page in full, then comparing what they publish to what an independent reviewer would need to verify their claims. Excellent means: named laboratory, batch-specific certificates, recent dates, analytical method disclosed, results not gated behind login. Good means most but not all of those. Fair means the page exists but the specifics are missing. Weak means the page exists but functions as marketing rather than documentation.
Contaminant testing scope was rated against what should be tested for a research compound delivered as a lyophilized powder. Purity by HPLC is the floor. Endotoxin testing matters because residual endotoxin is the most common contaminant in microbial-fermentation or recombinant synthesis. Heavy metals and residual solvents matter more variably depending on synthesis route. Excellent vendors test all three, name the analytical standards, and publish results per batch.
Ingredient sourcing disclosure asks the question many vendors most want to avoid: where, specifically, was this peptide synthesized? Was the active material made in the United States, or was it imported in bulk and repackaged? Excellent vendors answer this question on their own initiative. Fair vendors will answer it if asked. Weak vendors don’t answer it at all.
Customer support quality was tested by submitting substantive questions — questions about endotoxin standards, batch sizes, lyophilization conditions — and noting response time and depth. Boilerplate replies dock a vendor regardless of how pleasant the tone. Reader correspondence supplemented my own direct testing.
Reorder-ability was the hardest dimension to score because it required either repeat orders or reader reports across multiple purchases. I weighted reader reports that came with photographs, lot numbers, or other documentation more heavily than impressions. A vendor whose product changes between batches without explanation cannot support a protocol that depends on consistency — and most worthwhile peptide work does.
This guide is not medical advice and is not a recommendation that you purchase any of the products discussed. Peptides referenced on this site are research compounds. The vendors evaluated above sell their products for research, laboratory, or analytical purposes only. Anyone considering peptide-based interventions for personal use should consult a licensed clinician familiar with their full health picture — not a website.
Where to read more on this site
The deeper context for why sourcing matters in the first place lives across several other pages here. If you’re newer to the question, the BPC-157 reference explains why even a well-studied peptide’s clinical signal depends on the purity of the material in the vial. The Peptides and Nutrition piece touches on bioidentical versus synthetic framing and where that distinction holds and where it dissolves. The Holistic Protocols overview explains why protocol consistency — the same material, batch over batch — is part of what makes a protocol actually work.
And for the methodology behind everything we publish — the editorial standards, the citation discipline, the non-relationship with vendors — the About page is the place to read first.